Lexaria Bioscience Corp (LEXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LEXX | AZN | AMGN | GILD | VRTX |
| Company | Lexaria Bioscience Corp | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.0800 | 88.51 | 336.74 | 124.81 | 440.02 |
| High | 1.0900 | 89.37 | 339.80 | 125.64 | 442.22 |
| Low | 1.0300 | 88.28 | 330.35 | 122.50 | 433.67 |
| Last | 1.0600 | 89.10 | 336.74 | 125.02 | 437.15 |
| Change | -0.0400 | +0.49 | +0.74 | -0.18 | +2.63 |
| % Change | -3.64% | +0.55% | +0.22% | -0.14% | +0.61% |
| Volume | 166,400 | 4,090,500 | 3,310,300 | 6,599,500 | 1,264,900 |
| 20-Day Average Volume | 232,860 | 4,493,160 | 2,613,435 | 6,857,210 | 1,412,620 |
| Previous Close | 1.1000 | 88.61 | 336.00 | 125.20 | 434.52 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.0199 | 84.30 | 308.52 | 121.48 | 423.39 |
| 20-Day Raw Stochastic | 58.99% | 96.31% | 84.27% | 80.53% | 87.02% |
| 20-Day Relative Strength | 52.72 | 65.90 | 71.84 | 60.63 | 62.00 |
| Weighted Alpha | -46.00 | +43.65 | +24.83 | +40.38 | -3.64 |
| Today's Opinion | 24% Buy | 100% Buy | 100% Buy | 100% Buy | 8% Buy |
| Previous Opinion | 24% Buy | 100% Buy | 100% Buy | 100% Buy | 8% Buy |
| Last Month's Opinion | 56% Sell | 100% Buy | 24% Buy | 88% Buy | 40% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.92% since 11/07/25 | +5.34% since 11/07/25 | +5.17% since 11/07/25 | +5.20% since 11/07/25 | +6.76% since 11/07/25 |
| Low | 1.0100 on 11/10/25 | 85.85 on 11/10/25 | 319.54 on 11/10/25 | 117.13 on 11/10/25 | 410.50 on 11/10/25 |
| High | 1.1500 on 11/12/25 | 89.43 on 11/13/25 | 345.84 on 11/13/25 | 127.68 on 11/13/25 | 442.22 on 11/14/25 |
| 1-Month | |||||
| %Chg | +21.28% since 10/14/25 | +4.68% since 10/14/25 | +14.60% since 10/14/25 | +5.52% since 10/14/25 | +6.05% since 10/14/25 |
| Low | 0.8003 on 10/17/25 | 80.48 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 403.16 on 11/04/25 |
| High | 1.2063 on 11/05/25 | 89.43 on 11/13/25 | 345.84 on 11/13/25 | 127.68 on 11/13/25 | 442.22 on 11/14/25 |
| 3-Month | |||||
| %Chg | +32.67% since 08/14/25 | +13.55% since 08/14/25 | +16.00% since 08/14/25 | +5.04% since 08/14/25 | +12.00% since 08/14/25 |
| Low | 0.7749 on 08/22/25 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 1.5500 on 09/25/25 | 89.43 on 11/13/25 | 345.84 on 11/13/25 | 127.68 on 11/13/25 | 442.22 on 11/14/25 |
| 6-Month | |||||
| %Chg | unch since 05/14/25 | +34.53% since 05/14/25 | +28.39% since 05/14/25 | +27.08% since 05/14/25 | +3.80% since 05/14/25 |
| Low | 0.7749 on 08/22/25 | 67.07 on 05/15/25 | 264.15 on 05/15/25 | 97.86 on 05/15/25 | 362.50 on 08/11/25 |
| High | 1.5500 on 09/25/25 | 89.43 on 11/13/25 | 345.84 on 11/13/25 | 127.68 on 11/13/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 23,560 | 276,335,104 | 181,328,096 | 155,109,824 | 110,913,264 |
| Shares Outstanding, K | 22,226 | 3,101,404 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 460,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -5,800,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 170,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -3,790,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 0.71 | 0.34 | 0.45 | 0.32 | 0.36 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.21 on 07/14/25 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 11/25/25 | 11/06/25 | 11/04/25 | 10/30/25 | 11/03/25 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 08/22/25 | 0.790 on 09/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 11/21/25 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.39 | 15.36 | 15.29 | 28.38 |